FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine
The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.
Read more on NPR
Wednesday, 21 April 2021
FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.